Penobscot Investment Management’s Edwards Lifesciences EW Stock Holding History

Penobscot Investment Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$872K	Hold	9,636	–	–	0.06%	178
2026 Q1	$772K	Hold	9,636	–	–	0.06%	186
2025 Q4	$821K	Sell	9,636 -4	-0%	-$328	0.06%	184
2025 Q3	$750K	Buy	9,640 +900	+10%	+$70.3K	0.06%	191
2025 Q2	$684K	Hold	8,740	–	–	0.06%	193
2025 Q1	$633K	Sell	8,740 -6,258	-42%	-$448K	0.06%	188
2024 Q4	$1.11M	Buy	+14,998	New	+$1.05M	0.1%	152
2022 Q4	–	Sell	-2,427	Closed	-$201K	–	225
2022 Q3	$201K	Hold	2,427	–	–	0.04%	217
2022 Q2	$231K	Hold	2,427	–	–	0.04%	211
2022 Q1	$286K	Hold	2,427	–	–	0.04%	207
2021 Q4	$314K	Buy	2,427 +27	+1%	+$3.15K	0.04%	208
2021 Q3	$272K	Hold	2,400	–	–	0.04%	211
2021 Q2	$249K	Hold	2,400	–	–	0.04%	215
2021 Q1	$201K	Hold	2,400	–	–	0.03%	218
2020 Q4	$219K	Buy	+2,400	New	+$199K	0.04%	201

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Penobscot Investment Management's EW Position: Q2 2026 in Review

Penobscot Investment Management held its Edwards Lifesciences (EW) position steady in Q2 2026 at 9,636 shares worth $872K. The position accounts for 0.06% of the portfolio, ranked #178.

Penobscot Investment Management first reported a position in EW in Q4 2020 and has held it in 15 quarters since. The position peaked at $1.11M in Q4 2024. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Penobscot Investment Management held 9,636 shares of Edwards Lifesciences worth $872K as of Q2 2026.
Penobscot Investment Management left its Edwards Lifesciences share count unchanged in Q2 2026.
Edwards Lifesciences made up 0.06% of Penobscot Investment Management's portfolio in Q2 2026, its #178 holding.
Penobscot Investment Management first reported a position in Edwards Lifesciences in Q4 2020 and has held it in 15 quarters since.
Penobscot Investment Management's Edwards Lifesciences position peaked at $1.11M in Q4 2024.
1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Penobscot Investment Management's 13F filing for Q2 2026, filed 24 Jul 2026.